Disease | hyperthermia |
Comorbidity | C0026946|fungal infection |
Sentences | 3 |
PubMedID- 22506121 | We wanted to emphasize these two specific products also because they have been subject of a “pharmacoeconomic study.” as a result of the analysis, that involved the two drugs in the empirical treatment of persistently febrile neutropenic patients with presumed fungal infection, ambisome was found to be more cost-effective compared to abelcet [32]. |
PubMedID- 20882524 | We prospectively examined the effect and safety of micafungin against febrile neutropenia with suspected fungal infection in 53 patients (median age, 56 years) who had undergone chemotherapy. |
PubMedID- 19942413 | Caspofungin is also licensed for empirical antifungal therapy of presumed fungal infections in patients with febrile neutropenia. |
Page: 1